Science|Business
Events
Date: 24 November 2011
Venue: UK Representation to the EU, Brussels
 Event Information
  • The Event
  • Supporters
  • Agenda
  • Featured Guests
  • Venue
  • Registration

Science|Business, in Partnership with The Vlerick Leuven Management School, will release a study on January 19th investigating the ability of ICT to radically increase the efficiency of personalised medicine and diagnostic stratification in oncology and cardio vascular disease.

This round table discussion will feature a first look at the EU wide implications of this research, and propose several concrete recommendations to improve the landscape for personalised health care in Europe.

Topics will include:

  • A summary presentation of the research results
  • The regulatory implications of scale, standardization, and investment
  • The role EU coordination and international collaboration could have

More information to be published soon, in the meantime: please contact events@sciencebusiness.net to find out more.


PRELIMINARY AGENDA



8:30 – 9:15

Registration

9:15 – 9:20

Welcome Address, His Excellency Mr. Jonathan Brenton, UK Ambassador to Belgium


9:20 – 9:35

Introductory Remarks, Zoran Stančič, Deputy Director-General, DG INFSO, European Commission


9:35 – 9:40

Background of the Project

Duane Schulthess, Commercial Director, Science|Business


9:40 – 10:15

The Preliminary Research Results

Walter Van  Dyck, Associate Professor of Innovation, Vlerick Leuven Gent Management School


10:15 –  10:25

Remarks - The Implications of  Stratification on EU Research Policy

Ruxandra Draghia-Akli, Director, Directorate Health, DG RTD, European Commission


10:25 – 11:10

Open Discussion: Diagnostics and ICT based monitoring at the EU policy level

11:10 – 11:30

Coffee break

11:30 – 12:45

Open Discussion II: Future technologies, policies, and approaches for EU 2020

12:45 – 14:00

Buffet Lunch

 
*
David Robinson
President, Speedo International Ltd.
*
His Excellency Mr. Jonathan Brenton
UK Ambassador to Belgium
*
Maria Iglesia Gomez
Head of Strategy and International Unit, DG SANCO, European Commission
*
Robert C. Wells
Head, Biotechnology Unit, OECD
*
Ruxandra Draghia-Akli
Director, Directorate Health, DG RTD, European Commission
*
Walter Van Dyck
Associate Professor of Innovation Management, Vlerick Leuven Gent Management School
*
Zoran Stančič
Deputy Director-General, DG INFSO, European Commission

UK Representation to the EU

More information to be published soon. Please contact events@sciencebusiness.net to find out more.

Advertisement